During periods of uncertainty, investors often pay closer attention to businesses that look built to withstand the noise.
When volatility picks up, the focus tends to shift toward companies with more resilient demand, stronger cash flow, and products that remain relevant regardless of the economic backdrop. That is what makes Pfizer and Merck worth putting side by side. Both are major healthcare companies that play important roles in global medicine while remaining relevant to investors seeking a mix of income, stability, and business strength.
